about
Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to ExpectWhole Tumor Antigen Vaccines: Where Are We?Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applicationsFibroblast activation protein α in tumor microenvironment: recent progression and implications (review)Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesisSynergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.Growth of MCF-7 breast cancer cells and efficacy of anti-angiogenic agents in a hydroxyethyl chitosan/glycidyl methacrylate hydrogel.Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2.Histological and molecular aspects of oral squamous cell carcinoma (Review)Colorectal cancer and basement membranes: clinicopathological correlations.Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosisHematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironmentFibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterationsMicroenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells.C-C chemokine receptor 5 on pulmonary mesenchymal cells promotes experimental metastasis via the induction of erythroid differentiation regulator 1.Imaging aspects of the tumor stroma with therapeutic implications.NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.Tumor gangliosides accelerate murine tumor angiogenesis.Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer.Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.Low-fidelity compensatory backup alternative DNA repair pathways may unify current carcinogenesis theories.Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology.Republished: Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology.Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells.Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance.Fibroblasts Enhance Migration of Human Lung Cancer Cells in a Paper-Based Coculture System.Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery.Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical ApplicationA role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.Tumor fibroblast specific activation of a hybrid ferritin nanocage-based optical probe for tumor microenvironment imaging.Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.Targeted Delivery to Tumor-associated Pericytes via an Affibody with High Affinity for PDGFRβ Enhances the in vivo Antitumor Effects of Human TRAIL.Tumor talk: understanding the conversation between the tumor and its microenvironment.The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.
P2860
Q26775578-E5D0960C-536C-4805-B4F9-196497B51715Q26783866-F5DB02FF-F510-47C3-9E54-866943AEF0FFQ28081554-93D33CCE-D215-48DA-892C-A85DD7CB9520Q28082504-2ED9C091-CB6A-41E7-BBE8-64FD3D2F70F3Q28389106-54D062AA-334A-471D-8A16-E28B96D0F32EQ33564844-15CFB1A9-823F-42AB-8C96-319835143742Q33696729-EC58AC96-A63A-41E8-BC39-0B4E821D6ADDQ33755480-92EC87EA-E759-4179-8583-5563B806DB2AQ34439455-2101CD71-885D-46CA-AED2-0B6F0E907ACFQ34662689-B587C7A9-4FA6-4764-B152-FAE65D5CC87CQ34968207-4FF09938-F4A3-42ED-9A17-27B47A9B6DAEQ35610828-1506DEA3-3AD1-43CA-A8F1-9FC569C3D32EQ35745090-4441A634-6BA3-43A0-BA5F-A2C19D94D7D4Q35754294-86C623BF-092F-4920-A4EB-C1C563340BE4Q36464398-8CE5E05E-5176-4185-941D-6FEC517009EBQ37018260-AADD7F06-C28D-4A1C-A6F7-729ACAE3DC43Q37033296-F55BF1F8-CC0F-437E-BCD4-0A4E80486E7EQ37600370-C8278F24-5BBB-4114-8349-8232D949AE0DQ37626064-041569A2-FF38-425A-B00B-7FDF822D5933Q37707767-36725A79-6BEB-4743-B467-5DC9596CBA72Q37732501-97048711-78F9-4F81-BBDB-D4B6B3A0196CQ38115617-DD0BE64F-8C79-408F-A280-3E1390520B44Q38188878-94B6B21A-1AB1-498A-955D-2B5AF055BB9CQ38221690-0A42CBF3-7317-4D40-8863-4BE661B94CDEQ38241160-1F1439BB-5F02-4288-8B8B-158A6BDFF476Q38481540-27DE6E4B-36C2-49C1-B7F9-63CF61C750A3Q38661469-23192384-B83F-434F-BB09-47D0D893AB71Q38748106-3D730A1D-6154-4402-A5F2-D2A098DECA49Q38808006-F2A4B315-4028-43AF-9CBD-70BD97864360Q38847679-3A7B8C88-78FA-44CB-8824-EC8BB6130EE2Q38912989-A9AD819B-648B-44ED-8140-E0012C2F7B82Q38951812-5E36E3E1-C653-4824-B932-9FD4009B29B7Q38964713-75D987EE-08EF-4AC8-B908-3F7AE7BD6081Q38967490-DCF13FB5-7858-4EB4-90C4-7CD3D607C861Q39013985-51B0B49D-4633-46C3-952B-C3516EEE755BQ39125873-675648F8-5D82-47C8-92E7-E776C7727452Q40226917-2FA871AF-C1B1-48E0-99C9-35B2119C2E1CQ40980397-F259222B-5972-4904-BDC7-B7BFB7F1C28DQ41061574-CB3BBB99-FBD2-4505-A0F3-1D2C35B0FE57Q41280225-90A57B05-10D7-4A92-B7A6-0EB2995A18E3
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tumor stroma as targets for cancer therapy
@ast
Tumor stroma as targets for cancer therapy
@en
Tumor stroma as targets for cancer therapy
@nl
type
label
Tumor stroma as targets for cancer therapy
@ast
Tumor stroma as targets for cancer therapy
@en
Tumor stroma as targets for cancer therapy
@nl
prefLabel
Tumor stroma as targets for cancer therapy
@ast
Tumor stroma as targets for cancer therapy
@en
Tumor stroma as targets for cancer therapy
@nl
P2860
P1476
Tumor stroma as targets for cancer therapy
@en
P2093
Jing Zhang
Jinsong Liu
P2860
P304
P356
10.1016/J.PHARMTHERA.2012.10.003
P407
P577
2013-02-01T00:00:00Z